IMPACT OF MEDICATION ADHERENCE ON DISEASE FLARE AMONG JAPANESE PATIENTS WITH RHEUMATOID ARTHRITIS

• At: AbuDhabi (United Arab Emirates) (2019)
• Type: Poster
• Poster code: POS-HPS-086
• By: NAKAGAWA, Shunsaku (Japan)
• Co-author(s): Shunsaku Nakagawa: Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Kyoto, Japan
  Mayumi Nakaishi: Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Kyoto, Japan
  Yoshiki Katada: Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Kyoto, Japan
  Shota Yamamoto: Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Kyoto, Japan
  Motomu Hashimoto: Department of Advanced Medicine for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japan
  Hiromu Ito: Department of Orthopedic Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
  Masao Tanaka: Department of Advanced Medicine for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japan
  Takao Fujii: Department of Clinical Immunology and Rheumatology, Wakayama Medical University, Wakayama, Japan
  Tomohiro Omura: Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Kyoto, Japan
  Satoshi Imai: Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Kyoto, Japan
  Takayuki Nakagawa: Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Kyoto, Japan
  Atsushi Yonezawa: Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Kyoto, Japan
  Hirohisa Imai: Department of Medical and Pharmaceutical Community Healthcare, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan
  Tsuneyo Mimori: Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
  Kazuo Matsubara: Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Kyoto, Japan
  
• Abstract:

  Background

  For the optimum efficacy of disease-modifying anti-rheumatic drugs (DMARDs), patients need to be adherent to their medication regimen.

  Methods

  Patients were enrolled from the Kyoto University RA Management Alliance cohort, and followed up prospectively for 12 months. In this study, a total of 481 patients were analyzed and divided into 4
  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login